| P50 | author | Anthony Gordon | Q57300688 |
| P2093 | author name string | James Tomlinson | |
| | Sophie Piper | |
| | James Leiper | |
| | Simon Lambden | |
| P2860 | cites work | What is the best method for estimating the burden of severe sepsis in the United States? | Q51378498 |
| | Protective role of DDAH2 (rs805304) gene polymorphism in patients with myocardial infarction. | Q51789370 |
| | Pharmacological inhibition of DDAH1 improves survival, haemodynamics and organ function in experimental septic shock. | Q53063266 |
| | Myocardial depression characterizes the fatal course of septic shock. | Q54269075 |
| | Circulatory Shock | Q56137044 |
| | Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction | Q57773627 |
| | High-performance liquid chromatographic determination of nitric oxide synthase-related arginine derivatives in vitro and in vivo | Q73286550 |
| | Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease | Q82983436 |
| | Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases | Q22010563 |
| | Sepsis: rethinking the approach to clinical research | Q22255578 |
| | Disruption of methylarginine metabolism impairs vascular homeostasis | Q27643718 |
| | Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studies | Q28087272 |
| | Reduced Renal Methylarginine Metabolism Protects against Progressive Kidney Damage | Q30300218 |
| | Asymmetric dimethylarginine, endothelial nitric oxide bioavailability and mortality in sepsis | Q31001162 |
| | Biological significance of endogenous methylarginines that inhibit nitric oxide synthases | Q33847583 |
| | Protocol for a randomised controlled trial of VAsopressin versus Noradrenaline as Initial therapy in Septic sHock (VANISH). | Q33879866 |
| | State of the arg: protein methylation at arginine comes of age. | Q34084396 |
| | Septic shock is correlated with asymmetrical dimethyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: a prospective observational study | Q35544768 |
| | The DDAH/ADMA/NOS pathway | Q35603929 |
| | Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock | Q35621102 |
| | L-arginine and asymmetric dimethylarginine are early predictors for survival in septic patients with acute liver failure | Q35961528 |
| | Evaluation of asymmetric dimethylarginine, arginine, and carnitine metabolism in pediatric sepsis | Q36083890 |
| | Judging quality of current septic shock definitions and criteria | Q36424765 |
| | Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond | Q36438224 |
| | Nitric oxide in shock | Q36835542 |
| | Is plasma arginine concentration decreased in patients with sepsis? A systematic review and meta-analysis | Q37819904 |
| | Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial | Q38389309 |
| | Association of the DDAH2 gene polymorphism with type 2 diabetes and hypertension | Q38462560 |
| | High Levels of Methylarginines Were Associated With Increased Mortality in Patients With Severe Sepsis | Q39749294 |
| | Regulation of biosynthesis of nitric oxide. | Q40389134 |
| | Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study | Q40397164 |
| | Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations | Q40491993 |
| | Markers of nitric oxide are associated with sepsis severity: an observational study | Q41033479 |
| | Circulating methylarginine levels and the decline in renal function in patients with chronic kidney disease are modulated by DDAH1 polymorphisms | Q43221823 |
| | Polymorphisms in the promoter region of the dimethylarginine dimethylaminohydrolase 2 gene are associated with prevalence of hypertension | Q43295548 |
| | Relationship between circulating levels of calcitonin gene-related peptide, nitric oxide metabolites and hemodynamic changes in human septic shock | Q44011999 |
| | Microvascular blood flow is altered in patients with sepsis | Q44045816 |
| | Nitrite/nitrate oxide (NOx) and cytokine levels in patients with septic shock | Q44723750 |
| | Dimethylarginine dimethylaminohydrolase 2 regulates nitric oxide synthesis and hemodynamics and determines outcome in polymicrobial sepsis | Q44901088 |
| | Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects. | Q45967633 |
| | Asymmetrical dimethylarginine plasma clearance persists after acute total nephrectomy in rats | Q46661250 |
| | Nitric oxide synthase (NOS) single nucleotide polymorphisms are associated with coronary heart disease and hypertension in the INTERGENE study | Q46770081 |
| | Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure | Q46861533 |
| | Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins | Q47663251 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | single-nucleotide polymorphism | Q501128 |
| | septic shock | Q1765564 |
| P304 | page(s) | 336 | |
| P577 | publication date | 2018-12-11 | |
| P1433 | published in | Critical Care | Q5186602 |
| P1476 | title | Evidence for a protective role for the rs805305 single nucleotide polymorphism of dimethylarginine dimethylaminohydrolase 2 (DDAH2) in septic shock through the regulation of DDAH activity | |
| P478 | volume | 22 | |